Which statement best describes a virtual manufacturer?

• A. Owns the drug but outsources manufacturing to a contract manufacturing organization and may use a third-party logistics provider.
• B. Owns the product and makes it in-house.
• C. Is only a distributor.
• D. Is a regulatory agency.

Answer: (A)

A virtual manufacturer is a company that owns the drug product but outsources the actual manufacturing to contract manufacturing organizations (CMOs), and may also use a third-party logistics provider for distribution. The key idea is ownership of the product combined with outsourcing production, while still maintaining control over formulation, quality, regulatory compliance, and the overall supply chain.

This arrangement allows the company to bring products to market without owning and operating its own manufacturing facilities. It relies on CMOs to produce batches under GMP, with the virtual manufacturer handling vendor selection, quality oversight, regulatory submissions, batch release, and supply-chain coordination. Using multiple CMOs can provide flexibility and resilience, while a 3PL can handle warehousing and distribution.

Why this fits best: it captures ownership of the drug and the decision to outsource production, plus potential outsourcing of logistics, which distinguishes it from owning manufacturing in-house, or from simply distributing finished products, or from acting as a regulatory body. The other roles either describe distributors (who don’t own manufacturing) or regulatory agencies (which aren’t involved in producing drugs).